IL1RN, interleukin 1 receptor antagonist, 3557

N. diseases: 701; N. variants: 52
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0021368
Disease: Inflammation
Inflammation
0.520 Therapeutic phenotype CTD_human IL-1 receptor antagonist attenuates neonatal lipopolysaccharide-induced long-lasting learning impairment and hippocampal injury in adult rats. 25665855 2015
CUI: C0021368
Disease: Inflammation
Inflammation
0.520 GeneticVariation phenotype LHGDN Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk. 16106254 2005
CUI: C0021368
Disease: Inflammation
Inflammation
0.520 Biomarker phenotype RGD Interleukin-1beta mediates the memory impairment associated with a delayed type hypersensitivity response to bacillus Calmette-Guérin in the rat hippocampus. 15050649 2004
CUI: C0021368
Disease: Inflammation
Inflammation
0.520 GeneticVariation phenotype LHGDN In order to further define the clinical impact of genetic variation in this potent proinflammatory pathway we investigated the joint effects of two single nucleotide polymorphisms in the interleukin-1 beta gene [IL-1B(-511) and IL-1B(+3954)] and a variable number tandem repeat polymorphism in intron 2 of the interleukin 1 receptor antagonist gene (IL-1RN VNTR) on postintervention inflammation and occurrence of restenosis in 183 consecutive patients who underwent successful femoropopliteal PTA. 12958619 2003